|
| Status |
Public on Aug 22, 2019 |
| Title |
Primary ovarian tumor, patient 3 |
| Sample type |
RNA |
| |
|
| Source name |
Primary Ovarian Tumor
|
| Organism |
Homo sapiens |
| Characteristics |
patientid: 3
well: A08
samplesource: Customer
sampletype: Fresh Frozen
tissue: Primary Ovarian Tumor
|
| Extracted molecule |
total RNA |
| Extraction protocol |
RNA was extracted from fresh frozen primary human HGSOC, metastatic HGSOC, or adjacent normal tissue from patients using the Qiagen RNeasy Plus Mini RNA isolation kit (cat: 74134).
|
| Label |
biotin
|
| Label protocol |
standard Illumina protocol
|
| |
|
| Hybridization protocol |
RNA samples were processed using the Clariom D Pico human Assay.
|
| Scan protocol |
standard Illumina protocol
|
| Description |
Gene expression data from primary ovarian tumor, patient 3
|
| Data processing |
Arrays were analyzed using SST-RMA algorithm in the Affymetrix Transcriptome Analysis Console (TAC) Software. All samples passed the quality control criteria given by Affymetrix. Probes with less than two arrays above the 95th percentile of the antigenomic background probes were filtered out. Here, we provide the CHP files with the SST-RMA normalization.
|
| |
|
| Submission date |
Sep 20, 2018 |
| Last update date |
Aug 22, 2019 |
| Contact name |
Kristin Gail Anderson |
| Organization name |
Fred Hutchinson Cancer Research Center
|
| Department |
Clinical Research Division
|
| Lab |
Philip Greenberg Lab
|
| Street address |
1100 Fairview Ave N
|
| City |
Seattle |
| State/province |
WA |
| ZIP/Postal code |
98109 |
| Country |
USA |
| |
|
| Platform ID |
GPL23126 |
| Series (2) |
| GSE120259 |
Engineered adoptive T cell therapy prolongs survival in a preclinical model of advanced stage ovarian cancer [Human] |
| GSE120264 |
Engineered adoptive T cell therapy prolongs survival in a preclinical model of advanced stage ovarian cancer |
|
